JDR JDR Most Read Articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dolce, C.
Right arrow Articles by Holliday, L.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dolce, C.
Right arrow Articles by Holliday, L.S.
J Dent Res 82(9): 682-686, 2003
© 2003 International and American Associations for Dental Research


RESEARCH REPORT
Biomaterials & Bioengineering

Effects of Echistatin and an RGD Peptide on Orthodontic Tooth Movement

C. Dolce*, A. Vakani, L. Archer, J.A. Morris-Wiman, and L.S. Holliday

Department of Orthodontics, College of Dentistry, University of Florida, Box 100444, JHMHC, Gainesville, FL 32610-0444;

* corresponding author, cdolce{at}dental.ufl.edu

We tested whether orthodontic tooth movement (OTM) could be blocked by local administration of echistatin or an arginine-glycine-aspartic acid (RGD) peptide, agents known to perturb bone remodeling, adjacent to maxillary molars in rats. These molecules were incorporated into ethylene-vinyl acetate (ELVAX), a non-biodegradable, sustained-release polymer. In vitro experiments showed that the echistatin and RGD peptide were released from ELVAX in active forms at levels sufficient to disrupt osteoclasts. Biotinylated RGD peptide was released from ELVAX into the PDL after surgical implantation. ELVAX loaded with either RGD peptide or echistatin and surgically implanted next to the maxillary molars inhibited orthodontic tooth movement (p < 0.01). The RGD peptide also reduced molar drift (p < 0.05). This study shows the feasibility of using ELVAX to deliver integrin inhibitors adjacent to teeth to limit local tooth movement in response to orthodontic forces.

KEY WORDS: integrins • orthodontic tooth movement • echistatin • RGD




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
G.E. Wise and G.J. King
Mechanisms of Tooth Eruption and Orthodontic Tooth Movement
J. Dent. Res., May 1, 2008; 87(5): 414 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
J. Zuo, L.A. Archer, A. Cooper, K.L. Johnson, L.S. Holliday, and C. Dolce
Nuclear Factor {kappa}B p65 Phosphorylation in Orthodontic Tooth Movement
J. Dent. Res., June 1, 2007; 86(6): 556 - 559.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2003 Institutional Access Guidelines